In 2025, the EMA and FDA each released regulatory guidance that impacts the development and approval processes for #biosimilars. Find out what this means for analytics and bioanalytics, clinical study design and commercialisation in our whitepaper. https://t.co/Viowdf3eea
#Biosimilars developers will need to rethink their approach to stay competitive in the coming years. Learn how regulatory shifts, advances in modality, the competitive landscape and other factors impact biosimilar strategy in the whitepaper.
Download: https://t.co/PmOcojtovo
ICON is proud to be named one of #TIME & #Statista’s World’s Best Companies of 2025 — for the third year running! A huge thank you to our teams worldwide https://t.co/aFqpOGnrJX
#WorldsBestCompanies
ICON’s charity donation program has supported over 130 charities with many worthy causes.
In 2024, 10 employee-nominated charities from around the world benefited by receiving a $10,000 donation each to support the valuable work they do. https://t.co/H5O2yG0RdK
Discover what ICON is doing to reduce our environmental impact, by progressing towards our validated SBTi targets through lowering our carbon emissions, increasing our use of renewable electricity and improving the sustainability of our offices: https://t.co/SWZf7UQkpI
ICON’s near-term, long-term and #netzero targets have been validated by #SBTi. In 2024 we decreased Scope 3 emissions 7.56% compared to 2022. Read more: https://t.co/bpWqcLn4tU
Congratulations to @ShopboxAI, the winner of the eCommerce Software Tool or App of the Year Award at the Irish eCommerce Awards 2023, powered by AIB Merchant Services. 🏆
Congratulations to all the team on your success! 🌟
#IrisheCommAwards#backedbyAIB